Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013445387> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2013445387 abstract "Positron Emission Tomography(PET)images show physiological and biological information through the in vivo distribution of radioactive, positron‐emitting agents. PETimaging shows focal and distributed regions of cancer and its metastases. Initial PET uses in oncology include diagnosis and staging, which are important for determining treatment decisions. Current PET uses now include target definition for radiation planning followed by PET‐based assessment of treatment. Hybrid PET‐CT devices are becoming attractive radiation treatment simulators. PETimaging has coarse spatial resolution compared to CT and MR. PET's clinical use is valued because of its great sensitivity for cancer detection. While F‐18‐labled Fluoro‐deoxyglucose (FDG) remains the most promising agent for tumor diagnosis and staging, other, biologically more specific agents (e.g., FMISO, CuATSM for hypoxia imaging or FLT for cell proliferation imaging) might be more appropriate for target definition and treatment assessment. Although PET brings to radiation therapy of cancer the critical advantage of defining the tumor based on its molecular properties, delineating the gross tumor volume (GTV) with PET is problematic due to the uncertainties in the biological and physiological processes governing the tracer uptake and due to physical limitations for the accuracy of PETimages. The main PETimage degrading factors, including limited resolution, photon scatter and attenuation will be described and some of the current correction strategies will be introduced. A brief summary of the PETimage segmentation methods will be presented. This course reviews PET‐CT hybrid scanning devices, uses of FDG and non‐FDG PET for oncologyimaging, and quantitative aspects for PET‐based radiation target definition and treatment assessment. Example images demonstrate the potential contributions and limitations of FDG and non‐FDG PEToncologyimaging. This review course is intended for both imaging and radiationoncology physicists. Learning Objectives 1. Understand the principle and the current physical limitations of PET 2. Become familiar with the types of PET‐based tumor segmentation methods 3. Discuss quantitative aspects of PETimaging for treatment assessment" @default.
- W2013445387 created "2016-06-24" @default.
- W2013445387 creator A5030203098 @default.
- W2013445387 creator A5057526853 @default.
- W2013445387 date "2009-06-01" @default.
- W2013445387 modified "2023-09-26" @default.
- W2013445387 title "TU-B-BRC-01: Promise and Challenges of PET for Target Definition and Treatment Response Evaluation" @default.
- W2013445387 doi "https://doi.org/10.1118/1.3182314" @default.
- W2013445387 hasPublicationYear "2009" @default.
- W2013445387 type Work @default.
- W2013445387 sameAs 2013445387 @default.
- W2013445387 citedByCount "0" @default.
- W2013445387 crossrefType "journal-article" @default.
- W2013445387 hasAuthorship W2013445387A5030203098 @default.
- W2013445387 hasAuthorship W2013445387A5057526853 @default.
- W2013445387 hasConcept C123688308 @default.
- W2013445387 hasConcept C126838900 @default.
- W2013445387 hasConcept C127077266 @default.
- W2013445387 hasConcept C136339569 @default.
- W2013445387 hasConcept C150903083 @default.
- W2013445387 hasConcept C19527891 @default.
- W2013445387 hasConcept C201645570 @default.
- W2013445387 hasConcept C207001950 @default.
- W2013445387 hasConcept C2775842073 @default.
- W2013445387 hasConcept C2989005 @default.
- W2013445387 hasConcept C3017724952 @default.
- W2013445387 hasConcept C41008148 @default.
- W2013445387 hasConcept C509974204 @default.
- W2013445387 hasConcept C71924100 @default.
- W2013445387 hasConcept C86803240 @default.
- W2013445387 hasConceptScore W2013445387C123688308 @default.
- W2013445387 hasConceptScore W2013445387C126838900 @default.
- W2013445387 hasConceptScore W2013445387C127077266 @default.
- W2013445387 hasConceptScore W2013445387C136339569 @default.
- W2013445387 hasConceptScore W2013445387C150903083 @default.
- W2013445387 hasConceptScore W2013445387C19527891 @default.
- W2013445387 hasConceptScore W2013445387C201645570 @default.
- W2013445387 hasConceptScore W2013445387C207001950 @default.
- W2013445387 hasConceptScore W2013445387C2775842073 @default.
- W2013445387 hasConceptScore W2013445387C2989005 @default.
- W2013445387 hasConceptScore W2013445387C3017724952 @default.
- W2013445387 hasConceptScore W2013445387C41008148 @default.
- W2013445387 hasConceptScore W2013445387C509974204 @default.
- W2013445387 hasConceptScore W2013445387C71924100 @default.
- W2013445387 hasConceptScore W2013445387C86803240 @default.
- W2013445387 hasLocation W20134453871 @default.
- W2013445387 hasOpenAccess W2013445387 @default.
- W2013445387 hasPrimaryLocation W20134453871 @default.
- W2013445387 hasRelatedWork W1972248519 @default.
- W2013445387 hasRelatedWork W1990157637 @default.
- W2013445387 hasRelatedWork W2006875080 @default.
- W2013445387 hasRelatedWork W2012356399 @default.
- W2013445387 hasRelatedWork W2054454436 @default.
- W2013445387 hasRelatedWork W2071280849 @default.
- W2013445387 hasRelatedWork W2100511663 @default.
- W2013445387 hasRelatedWork W2113775666 @default.
- W2013445387 hasRelatedWork W2157862901 @default.
- W2013445387 hasRelatedWork W2331875104 @default.
- W2013445387 hasRelatedWork W2340011067 @default.
- W2013445387 hasRelatedWork W2347145067 @default.
- W2013445387 hasRelatedWork W2469371765 @default.
- W2013445387 hasRelatedWork W2470098656 @default.
- W2013445387 hasRelatedWork W2471620288 @default.
- W2013445387 hasRelatedWork W2473790249 @default.
- W2013445387 hasRelatedWork W2604531311 @default.
- W2013445387 hasRelatedWork W2891363744 @default.
- W2013445387 hasRelatedWork W2141586824 @default.
- W2013445387 hasRelatedWork W2539022877 @default.
- W2013445387 isParatext "false" @default.
- W2013445387 isRetracted "false" @default.
- W2013445387 magId "2013445387" @default.
- W2013445387 workType "article" @default.